233 related articles for article (PubMed ID: 20854435)
21. Anti-laminin gamma-1 pemphigoid.
Dainichi T; Kurono S; Ohyama B; Ishii N; Sanzen N; Hayashi M; Shimono C; Taniguchi Y; Koga H; Karashima T; Yasumoto S; Zillikens D; Sekiguchi K; Hashimoto T
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2800-5. PubMed ID: 19196964
[TBL] [Abstract][Full Text] [Related]
22. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.
Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF
Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of anti-laminin γ-1 pemphigoid by immunoblot analysis.
Solimani F; Pollmann R; Ishii N; Eming R; Hashimoto T; Schmidt T; Hertl M
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):735-741. PubMed ID: 29972879
[TBL] [Abstract][Full Text] [Related]
24. Pathogenicity of autoantibodies in anti-p200 pemphigoid.
Vafia K; Groth S; Beckmann T; Hirose M; Dworschak J; Recke A; Ludwig RJ; Hashimoto T; Zillikens D; Schmidt E
PLoS One; 2012; 7(7):e41769. PubMed ID: 22911854
[TBL] [Abstract][Full Text] [Related]
25. [Anti-p200 pemphigoid: clinical, diagnostic and therapeutic aspects].
Drerup KA; Wehkamp U
Hautarzt; 2020 Feb; 71(2):130-133. PubMed ID: 31501972
[TBL] [Abstract][Full Text] [Related]
26. A Korean case of anti-p200 pemphigoid.
Cho SB; Kim SC
Yonsei Med J; 2003 Oct; 44(5):931-4. PubMed ID: 14584115
[TBL] [Abstract][Full Text] [Related]
27. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
28. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
[TBL] [Abstract][Full Text] [Related]
29. Modern diagnosis of autoimmune blistering skin diseases.
Schmidt E; Zillikens D
Autoimmun Rev; 2010 Dec; 10(2):84-9. PubMed ID: 20713186
[TBL] [Abstract][Full Text] [Related]
30. Metastatic ovarian carcinoma-associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features.
Mitsuya J; Hara H; Ito K; Ishii N; Hashimoto T; Terui T
Br J Dermatol; 2008 Jun; 158(6):1354-7. PubMed ID: 18294311
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
Gao SQ; Bystryn JC
J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
[TBL] [Abstract][Full Text] [Related]
32. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
[TBL] [Abstract][Full Text] [Related]
33. Use of animal skin substrates for indirect immunofluorescence diagnosis of subepidermal autoimmune bullous diseases.
Kanitakis J; Cozzani E; Peyron E; Bourchany D; Claudy A
Arch Dermatol; 1994 Dec; 130(12):1558. PubMed ID: 7986134
[No Abstract] [Full Text] [Related]
34. A severe and refractory case of anti-p200 pemphigoid resulting in multiple skin ulcers and scar formation.
Goto-Ohguchi Y; Nishie W; Akiyama M; Tateishi Y; Aoyagi S; Tsuji-Abe Y; Sawamura D; Ishii N; Hashimoto T; Shimizu H
Dermatology; 2009; 218(3):265-71. PubMed ID: 19060472
[TBL] [Abstract][Full Text] [Related]
35. An attempt to develop mouse model for anti-laminin γ1 pemphigoid.
Koga H; Ishii N; Dainichi T; Tsuruta D; Hamada T; Ohata C; Karashima T; Furumura M; Hashimoto T
J Dermatol Sci; 2013 May; 70(2):108-15. PubMed ID: 23410740
[TBL] [Abstract][Full Text] [Related]
36. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
39. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid.
Natsuga K; Nishie W; Shinkuma S; Moriuchi R; Shibata M; Nishimura M; Hashimoto T; Shimizu H
Br J Dermatol; 2010 Mar; 162(3):513-7. PubMed ID: 19751242
[TBL] [Abstract][Full Text] [Related]
40. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
